Type 2 Diabetes (T2D): All Insulin Options on the Table in the UAE – Dubai Health Authority

Upon completion of this program, participants will be able to:

1. Examine the barriers to insulin initiation, titration and intensification in T2D
2. Discuss the burden of hypoglycaemia in the management of T2D with insulin and the relevance of glucose variability
3. Differentiate new rapid and long acting basal analogues from older agents and their impact on hypoglycaemia and glucose variability
4. Know when and how to switch from one insulin to another
5. Assess the benefit of emerging fixed-ratio combinations of basal-insulin plus GLP-1R agonist